Cardiff Oncology, Inc. - CRDF

About Gravity Analytica
Recent News
- 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 09.09.2025 - H.C. Wainwright 27th Annual Global Investment Conference
- 08.28.2025 - Cardiff Oncology to Participate in Three Upcoming Investor Conferences
- 08.28.2025 - Cardiff Oncology to Participate in Three Upcoming Investor Conferences
- 07.29.2025 - CRDF-004 First-Line RAS-mutated mCRC Trial Update
- 07.29.2025 - CRDF-004 First-Line RAS-mutated mCRC Trial Update
- 07.29.2025 - Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
- 07.29.2025 - Cardiff Oncology Announces Positive Data from Ongoing Randomized Phase 2 First-line RAS-mutated mCRC Clinical Trial (CRDF-004)
- 07.29.2025 - Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
- 07.29.2025 - Cardiff Oncology Reports Second Quarter 2025 Results and Provides Business Update
Recent Filings
- 08.14.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
- 07.31.2025 - 4 Statement of changes in beneficial ownership of securities
- 07.29.2025 - 8-K Current report
- 07.29.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
- 07.29.2025 - EX-99.1 EX-99.1
- 07.29.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors